Somewhat OT in relation to posts of the past couple days. However, once mgmt. fully understands what Vyrologix is and what it accomplishes as a therapeutic, trials for just about any condition can be completed relatively quickly.

I believe someone mentioned chronic fatigue syndrome in a post somewhere along the line. Unless there has been some unknown cataclysmic shift, we know that safety has been shown in well over a thousand patients. If the medical team believed Vyrologix might be effective against CFS or Alzheimers or any other condtion potentially created by cytokine inflammation, there should be a relatively short period for trials, start to finish, as compared to other therapeutics.

If statistically signifcant efficacy is shown against COVID, it can be tried with a host of other conditions beyond what mgmt. has mentioned to date. There's that word potential again, but there is truly life-enhancing potential for Cytodyn.